# Terazosin

NDC: 69452-331
Generic name: Terazosin
Labeler / Manufacturer: Bionpharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240311

FDA application: ANDA075667

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69452-331"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69452-331
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=130c84dc-b598-660f-e063-6294a90a8e46